Your browser doesn't support javascript.
loading
Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.
Mizuno, Shohei; Takami, Akiyoshi; Kawamura, Koji; Shimomura, Yoshimitsu; Arai, Yasuyuki; Konuma, Takaaki; Ozawa, Yukiyasu; Sawa, Masashi; Ota, Shuichi; Takahashi, Satoshi; Anzai, Naoyuki; Hiramoto, Nobuhiro; Onizuka, Makoto; Nakamae, Hirohisa; Tanaka, Masatsugu; Murata, Makoto; Kimura, Takafumi; Kanda, Junya; Fukuda, Takahiro; Atsuta, Yoshiko; Yanada, Masamitsu.
Afiliación
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan. Electronic address: shohei@aichi-med-u.ac.jp.
  • Takami A; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Kawamura K; Department of Hematology, Tottori University Hospital, Yonago, Japan.
  • Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Arai Y; Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan.
  • Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Takahashi S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Anzai N; Department of Hematology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Nakamae H; Department of Hematology, Osaka City University Hospital, Osaka, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
  • Kanda J; Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Transplant Cell Ther ; 28(11): 775.e1-775.e9, 2022 11.
Article en En | MEDLINE | ID: mdl-35921987
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article